Whether Covered California covers Zepbound depends on the carrier you enrolled with. Some marketplace plans will pay for it under narrow conditions, others exclude weight-loss medications almost entirely, and every plan that does cover it requires prior authorization plus clinical criteria that are typically stricter than the FDA’s approved indications. There is no across-the-board answer, because each Covered California insurer maintains its own formulary and California’s Essential Health Benefits benchmark plan does not include anti-obesity drugs.1MedicareResources.org. Will Your Health Insurance Cover Weight Loss Medications2Covered California. Prescriptions
Zepbound (tirzepatide) is FDA-approved for chronic weight management in adults with a BMI of 30 or greater, or 27 or greater with at least one weight-related condition.3FDA. Zepbound Prescribing Information In December 2024 it also became the first drug approved for moderate-to-severe obstructive sleep apnea in adults with obesity, which matters because it opens a coverage path some insurers treat separately from weight loss.4FDA. FDA Approves First Medication for Obstructive Sleep Apnea
Coverage by Carrier
Blue Shield of California
As of January 1, 2025, Zepbound is no longer automatically covered for Blue Shield commercial HMO and PPO members, including Covered California enrollees. Coverage now requires prior authorization and a determination of medical necessity specifically for Class III (morbid) obesity, meaning a BMI of 40 or higher. Members must also be participating in a comprehensive weight-loss program that includes a reduced-calorie diet, physical activity, and behavioral therapy. Anyone who does not meet those requirements pays the full cost.5Blue Shield of California. Weight Loss Medication Coverage Change Fact Sheet Effective July 1, 2026, Blue Shield began requiring members to transition to the multi-dose Zepbound KwikPen formulation.6Blue Shield of California. Provider News New PPO Savings Plans launching in 2027 are expected to expand coverage to members with a BMI of 30 or higher, or 27 with weight-related conditions.7Word & Brown. Weight Loss Drugs (GLP-1) Coverage
Health Net
Health Net lists Zepbound as a covered injectable weight-loss medication on its individual and family plans, including the Ambetter HMO and PPO plans sold through Covered California, subject to prior authorization.8Health Net. Weight Loss Medications Coverage Criteria Marketplace enrollees generally must have a BMI of 40 or higher, plus at least six months of documented enrollment in an approved weight-loss program before starting the drug.9Health Net. Clinical Policy for Tirzepatide The standard cost share is 50% coinsurance. Members already receiving a GLP-1 for a BMI of 30 or higher may be grandfathered if their provider continues the prescription.10Health Net. Weight Loss Drug Buy-Up Flyer
Anthem Blue Cross
Anthem reclassified all GLP-1 medications as non-formulary Tier 4 specialty drugs on January 1, 2025. Prior authorization is required, and requests for weight-loss purposes are typically denied as a plan exclusion. Claims for GLP-1s began being denied around October 2024, and authorization is now required even for non-obesity indications.7Word & Brown. Weight Loss Drugs (GLP-1) Coverage
Kaiser Permanente
Zepbound is not on Kaiser’s standard commercial HMO formulary.11Kaiser Permanente. Commercial HMO Formulary Kaiser’s general policy allows non-formulary drugs to be covered if a Kaiser physician determines the drug is medically appropriate and necessary, based on specific clinical criteria. Out-of-pocket costs depend on the member’s plan.7Word & Brown. Weight Loss Drugs (GLP-1) Coverage
UnitedHealthcare
UnitedHealthcare’s California fully insured plans cover Zepbound with prior authorization. Members must have a BMI of 30 or higher (or 27 with an obesity-related comorbidity) and participate in a motivation-based wellness program. The medication generally falls under Tier 3.7Word & Brown. Weight Loss Drugs (GLP-1) Coverage UnitedHealthcare also runs a separate coverage pathway for Zepbound prescribed for obstructive sleep apnea, with its own clinical prerequisites.12UnitedHealthcare. Clinical Pharmacy Program for Zepbound
Smaller and Regional Carriers
Sutter Health Plan covers medications for morbid obesity (BMI of 40 or higher), classifies Zepbound as a non-formulary Tier 4 drug, and requires six months of enrollment in its “Vida” program. Western Health Advantage does not include GLP-1 weight-loss drugs on its formulary but allows a non-formulary exceptions process for members with a BMI above 40. Prominence Health Plan and MediExcel exclude GLP-1 coverage for weight loss altogether and limit access to patients with documented type 2 diabetes.7Word & Brown. Weight Loss Drugs (GLP-1) Coverage
What You’ll Need to Qualify
The specifics differ, but the requirements repeat across every Covered California carrier that offers any path to coverage.
- Prior authorization. Your prescriber must submit documentation to the insurer before a pharmacy can fill the prescription. Processing usually takes one to seven business days, sometimes longer.13Eli Lilly. Zepbound Access and Coverage
- A high BMI. The FDA label starts at 27 with a comorbidity, but several Covered California carriers require 40 or above for marketplace enrollees.9Health Net. Clinical Policy for Tirzepatide
- A weight-management program. Most plans want documentation of at least six months in a structured program combining diet, exercise, and behavioral modification, continued during treatment.5Blue Shield of California. Weight Loss Medication Coverage Change Fact Sheet
- Step therapy. Some insurers require you to try and fail on lower-cost medications first, commonly phentermine, Contrave, Qsymia, or Wegovy.14FindHonestCare. Zepbound Prior Authorization
- Reauthorization. Approvals typically last six to twelve months, and renewal often requires proof of at least a 5% reduction in baseline body weight.
The Sleep Apnea Route
Zepbound’s approval for moderate-to-severe obstructive sleep apnea creates a coverage door that stays open even on some plans that exclude weight-loss drugs.4FDA. FDA Approves First Medication for Obstructive Sleep Apnea No other GLP-1 carries this indication, which gives patients with a qualifying diagnosis a strong basis to request a formulary exception.
To qualify this way you generally need a sleep study showing an apnea-hypopnea index of 15 or more events per hour, a BMI of at least 30, and clinical documentation tying the prescription to the sleep disorder rather than to weight loss. Some plans also want evidence that you have tried or cannot use CPAP therapy. Coding the prescription under the ICD-10 code for obstructive sleep apnea, not obesity, is critical for the claim to be processed through this route.12UnitedHealthcare. Clinical Pharmacy Program for Zepbound
What Zepbound Costs Without Coverage
If your plan denies Zepbound or you can’t clear prior authorization, the out-of-pocket cost is substantial. The wholesale list price ranges from $499 to about $1,086 for a 28-day supply.15Eli Lilly. Zepbound Pricing Information Retail pharmacy prices for the single-dose pen average around $1,291 per month.16GoodRx. Zepbound Cost
Eli Lilly runs three savings pathways, each with its own conditions:
- If your plan covers Zepbound, Lilly’s savings card can bring your cost as low as $25 per month, capped at $1,300 in annual savings.17Eli Lilly. Zepbound Savings
- If you have private insurance but no coverage for Zepbound, the KwikPen starts at $299 per month for the lowest dose and $449 for higher doses, and the single-dose pen is available at around $499.
- If you’re paying entirely out of pocket, Lilly’s Self Pay Journey Program offers similar KwikPen pricing — $299 for the 2.5 mg dose and $449 for 7.5 mg and above — as long as you complete refills within 45 days.18Eli Lilly. Zepbound Coverage and Savings for HCPs
All Lilly savings programs expire December 31, 2026. Anyone on Medicare, Medicaid, TRICARE, or VA benefits is not eligible for any of these discounts.17Eli Lilly. Zepbound Savings
If Your Claim Is Denied
Denials are common, and you have several ways to push back. If the denial rests on a plan exclusion for weight-loss drugs and you have a qualifying obstructive sleep apnea diagnosis, ask that the claim be reprocessed under that indication. If the denial cites lack of medical necessity, your prescribing physician can submit a letter of medical necessity with supporting clinical documentation. Lilly publishes a medical appeals guide for providers and notes that multiple rounds of appeals are sometimes needed.13Eli Lilly. Zepbound Access and Coverage Covered California advises consumers to check directly with their insurer to confirm coverage for a specific prescription and to understand their appeal rights.2Covered California. Prescriptions
A Note on Medi-Cal
None of the rules above apply if you’re on Medi-Cal rather than a Covered California marketplace plan. The two programs are accessed through the same application but operate under different rules, and this is an easy point of confusion. Effective January 1, 2026, Medi-Cal stopped covering Zepbound, Wegovy, and Saxenda when prescribed for weight loss in adults 21 and older, though coverage continues for type 2 diabetes, cardiovascular disease, chronic kidney disease, and — for Zepbound — obstructive sleep apnea.19Medi-Cal Rx. Important Update on GLP-1s for Weight Loss20California Medical Association. GLP-1 Medications for Weight Loss Will No Longer Be Covered by Medi-Cal If your income changes and you move between the two programs, expect your coverage rules to change with it.